ACE2/ANG-(1-7)/Mas pathway in the brain: the axis of good.
about
Autonomic-Immune-Vascular Interaction: An Emerging Concept for Neurogenic HypertensionThe compensatory renin-angiotensin system in the central regulation of arterial pressure: new avenues and new challengesNeuroprotective mechanisms of the ACE2-angiotensin-(1-7)-Mas axis in strokeAngiotensin peptides and nitric oxide in cardiovascular diseaseDivergent mechanism regulating fluid intake and metabolism by the brain renin-angiotensin systemThe Concise Guide to PHARMACOLOGY 2013/14: enzymes.From gene to protein-experimental and clinical studies of ACE2 in blood pressure control and arterial hypertensionEstrogen regulation of the brain renin-angiotensin system in protection against angiotensin II-induced sensitization of hypertension.Overexpression of angiotensin-converting enzyme 2 attenuates tonically active glutamatergic input to the rostral ventrolateral medulla in hypertensive rats.Deficiency of angiotensin-converting enzyme 2 causes deterioration of cognitive function.Evidence for an angiotensin-(1-7) neuropeptidase expressed in the brain medulla and CSF of sheep.Classical Renin-Angiotensin system in kidney physiologyActivation of the ACE2/Ang-(1-7)/Mas pathway reduces oxygen-glucose deprivation-induced tissue swelling, ROS production, and cell death in mouse brain with angiotensin II overproduction.Angiotensin-(1-7) in paraventricular nucleus modulates sympathetic activity and cardiac sympathetic afferent reflex in renovascular hypertensive ratsAngiotensin-converting enzyme 2 over-expression in the central nervous system reduces angiotensin-II-mediated cardiac hypertrophyAngiotensin II mediates angiotensin converting enzyme type 2 internalization and degradation through an angiotensin II type I receptor-dependent mechanism.Angiotensin II and angiotensin-(1-7) in paraventricular nucleus modulate cardiac sympathetic afferent reflex in renovascular hypertensive ratsAngiotensin-(1-7) induces cerebral ischaemic tolerance by promoting brain angiogenesis in a Mas/eNOS-dependent pathway.Inhibition of TNF in the brain reverses alterations in RAS components and attenuates angiotensin II-induced hypertensionStabilization of the angiotensin-(1-7) receptor Mas through interaction with PSD95.Brain-targeted angiotensin-converting enzyme 2 overexpression attenuates neurogenic hypertension by inhibiting cyclooxygenase-mediated inflammation.Mechanisms of brain renin angiotensin system-induced drinking and blood pressure: importance of the subfornical organ.Brain endogenous angiotensin II receptor type 2 (AT2-R) protects against DOCA/salt-induced hypertension in female ratsBrain-derived neurotrophic factor modulates angiotensin signaling in the hypothalamus to increase blood pressure in rats.Cerebroprotection by angiotensin-(1-7) in endothelin-1-induced ischaemic stroke.Species-specific inhibitor sensitivity of angiotensin-converting enzyme 2 (ACE2) and its implication for ACE2 activity assaysAngiotensin-converting enzyme 2: the first decade.Angiotensin II-induced hypertension is modulated by nuclear factor-κBin the paraventricular nucleus.ACE2 overexpression in the paraventricular nucleus attenuates angiotensin II-induced hypertensionBrain angiotensin-converting enzyme type 2 shedding contributes to the development of neurogenic hypertension.Sensitization of slow pressor angiotensin II (Ang II)-initiated hypertension: induction of sensitization by prior Ang II treatment.Effect of a Selective Mas Receptor Agonist in Cerebral Ischemia In Vitro and In Vivo.Activation of angiotensin II type 2 receptor suppresses TNF-α-induced ICAM-1 via NF-кB: possible role of ACE2α-Lipoic acid reduces neurogenic hypertension by blunting oxidative stress-mediated increase in ADAM17.Aging, the Central Nervous System, and Mobility in Older Adults: Neural Mechanisms of Mobility ImpairmentCentral Infusion of Angiotensin II Type 2 Receptor Agonist Compound 21 Attenuates DOCA/NaCl-Induced Hypertension in Female Rats.Angiotensin II AT(1) receptor blockers as treatments for inflammatory brain disorders.Aldosterone acting through the central nervous system sensitizes angiotensin II-induced hypertension.Angiotensin-converting enzyme 2 activator diminazene aceturate prevents lipopolysaccharide-induced inflammation by inhibiting MAPK and NF-κB pathways in human retinal pigment epithelium.Angiotensin converting enzyme 2/Ang-(1-7)/mas axis protects brain from ischemic injury with a tendency of age-dependence
P2860
Q22306336-3AD2F935-2520-476C-B841-DA2C9818C0CCQ26823573-EF7D1F13-2D0B-4A74-86FE-542E5AB7A6ABQ26998948-9F70A625-2EBB-4349-8884-BA92D8F33ACAQ27022788-77480BB9-A136-4DAC-A58A-63C46117BEB1Q27023126-A2CF21C6-EDFF-4F9D-AD88-6518A8BCB527Q30486745-E432FFD1-C10D-4FBD-9BFA-CAF9DE173F86Q33795353-868597D8-7DC4-4823-B5E5-983CC1768AAEQ33913133-386E3C93-79B6-4603-A6D6-40B1893026B3Q33913160-42217FCA-42D7-4802-898B-2296BF542AC0Q33914333-F15ABDB5-A0F5-4318-8632-24C640DBB889Q34063513-C48E586D-434E-4FC7-B241-0E115E29F1F7Q34065655-87076DDA-8B70-439D-A6A3-5C15C059F183Q34158064-D0F291D7-2E4D-468B-8FD9-751FF0233E92Q34472153-DD6C81A6-6D20-4740-A89B-B55C23C6C9C0Q34479181-3D59C787-1C5F-4AF5-9E67-924FA7654D94Q34510691-D078DBF4-0AE6-4EA0-946C-B826D3E7FF10Q34534106-F40E59BC-BA46-4911-A3A4-A0D8FCCD7319Q34559574-B31116B0-C417-4315-A95A-FEA4E28A0B90Q34731058-5115DD12-0FDC-4BF7-9A43-B702E7EAE14DQ34735823-3DB65288-D38B-4466-A4B5-C56A83070129Q35079417-E7055659-DA0F-4A18-9574-BCB6F8B749C4Q35141354-A877C415-0DB1-441E-8BB4-C08D74D75881Q35166544-EFEAB8A5-FB49-4430-AADE-5DD2117B1C68Q35178667-C1982784-B320-4D5E-8B34-ADA587A91FAEQ35534662-2576E6CD-577E-4C27-8747-4C6C4EF66A22Q35543390-B8454892-5534-4334-98C6-B081740193A5Q35550937-6ACFA1CF-B641-4CF0-BB69-5DEBF098A358Q35707198-164553C8-9210-4C9A-8703-07BBC55542DBQ35776364-DDA4A3C6-FDF7-4041-865B-B4DFDCC727B9Q35776904-B5A587BA-8083-4166-8623-99A92E302461Q35812259-CC5466BC-14E8-4C70-922F-96377AC74673Q35833441-53E9DF33-471F-4199-80A0-6EA168AB3305Q36114299-64A15C98-97A0-4E56-80B7-79F71A4A1961Q36114331-76370F6B-8841-40F1-AD31-361F8D170011Q36276474-377A159B-2129-40E2-8EAD-224BE619C521Q36405259-84AEF159-ECFE-498E-8130-A12632BF77F5Q36410269-BCB117C9-770D-40A0-A225-07040A0867FAQ36501950-01CA2A6E-0FC9-4CFD-8F8F-7ABB7A53F1B5Q36565868-2CCB0849-575A-4343-8FE7-7ED934ED4C9DQ36825182-EC24D94B-87E7-4C2A-8865-F86CFC74F792
P2860
ACE2/ANG-(1-7)/Mas pathway in the brain: the axis of good.
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
ACE2/ANG-
@nl
ACE2/ANG-(1-7)/Mas pathway in the brain: the axis of good.
@ast
ACE2/ANG-(1-7)/Mas pathway in the brain: the axis of good.
@en
type
label
ACE2/ANG-
@nl
ACE2/ANG-(1-7)/Mas pathway in the brain: the axis of good.
@ast
ACE2/ANG-(1-7)/Mas pathway in the brain: the axis of good.
@en
prefLabel
ACE2/ANG-
@nl
ACE2/ANG-(1-7)/Mas pathway in the brain: the axis of good.
@ast
ACE2/ANG-(1-7)/Mas pathway in the brain: the axis of good.
@en
P2860
P1476
ACE2/ANG-(1-7)/Mas pathway in the brain: the axis of good
@en
P2093
Eric Lazartigues
P2860
P304
P356
10.1152/AJPREGU.00222.2010
P577
2010-12-22T00:00:00Z